News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) CEO Aggressively Seeking Deals, Leaves Investors Guessing On AstraZeneca PLC (AZN) Intentions


7/30/2014 6:06:04 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - Pfizer Inc (PFE.N), which in May abandoned its $118 billion bid for AstraZeneca Plc (AZN.L), on Tuesday left investors guessing whether it would renew its pursuit of its British rival, but said it was considering other deals.

The largest U.S. drugmaker reported higher-than-expected second-quarter revenue, helped by growing demand for its cancer medicines. But overall sales fell on competition with newer rival drugs and cheaper generics, trends that have quickened Pfizer’s efforts to buy companies and drugs that can fortify its medicine chest.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Wall Street Journal
Read at Bloomberg


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES